The different prognostic impact of type-1 or type-1 like and type-2 or type-2 like CALR mutations in patients with primary myelofibrosis.

Li B, Xu Z, Li Y, Peter Gale R, Song Z, Ai X, Qin T, Zhang Y, Zhang P, Huang G, Xiao Z
Am J Hematol 91 E320-1 01/01/2016

Abstract

Full Text